Retrieve available abstracts of 14 articles: HTML format
Single Articles
April 2025
AIJALA VK, Sirnio P, Elomaa H, Karjalainen H, et al Significance of mucin-suspended tumor bud-like structures in colorectal cancer.
Hum Pathol. 2025;158:105772. PubMedAbstract available
March 2025
ZHU X, Meng X, Mochel MC, Wiliams EA, et al CYLD-mutated anal squamous cell carcinoma: An uncommon entity associated with
cylindroma-like morphology and adverse clinical features.
Hum Pathol. 2025;157:105765. PubMedAbstract available
February 2025
LEE SH, Pankaj A, Yilmaz O, Deshpande V, et al Beta-2-microglobulin positive tumor cells and CD8 positive lymphocytes are
associated with outcome in post-neoadjuvant colorectal cancer resections.
Hum Pathol. 2025;155:105737. PubMedAbstract available
January 2025
LASOTA J, Kaczorowski M, Chlopek M, Milek-Krupa J, et al An immunohistochemical and molecular genetic study of 60 colorectal carcinoma
brain metastases in pursuit of predictive biomarkers for cancer therapy.
Hum Pathol. 2025;155:105717. PubMedAbstract available
December 2024
XU Z, Theisen BK, Chang Q, Schultz D, et al Survival outcomes of poorly differentiated colorectal carcinoma variants:
Insights from a single teaching institute.
Hum Pathol. 2024;154:105710. PubMedAbstract available
September 2024
RERKPICHAISUTH V, Lau RP, Meyerson C, Fishbein GA, et al The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and
villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish
pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma.
Hum Pathol. 2024;151:105627. PubMedAbstract available
August 2024
LANSOM J, Liew I, Ng KS, Ly T, et al Right vs. Left Colorectal Cancer - Where Do We Draw the Line?
Hum Pathol. 2024 Aug 6:105634. doi: 10.1016/j.humpath.2024.105634. PubMedAbstract available
July 2024
JAN YH, Lu CT, Lam AK Comparison of genomic profiling of patient-matched primary colorectal and
surgical resected distant metastatic (stage IV) colorectal carcinoma for drug
actionability.
Hum Pathol. 2024;149:21-28. PubMedAbstract available
June 2024
CHALLA B, Frankel WL, Knight D, Pearlman R, et al EPM2AIP1 Immunohistochemistry Is Inadequate as A Surrogate Marker for MLH1
Promoter Hypermethylation Testing in Colorectal Cancer.
Hum Pathol. 2024 Jun 28:S0046-8177(24)00125. PubMedAbstract available
March 2024
HO YH, Hsu CY, Yau Li AF, Liang WY, et al Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine
neoplasm: Prognostic factors and PD-L1 expression.
Hum Pathol. 2024;145:80-85. PubMedAbstract available
VOS AM, Pijnenborg L, van Vliet S, Kodach LL, et al Biological background of colorectal polyps and carcinomas with heterotopic
ossification: A national study and literature review.
Hum Pathol. 2024;145:34-41. PubMedAbstract available
SUGAI T, Uesugi N, Osakabe M, Yao T, et al Characterization of sessile serrated adenomas with dysplasia including
intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite
instability phenotype.
Hum Pathol. 2024;145:9-15. PubMedAbstract available
February 2024
PIHLMANN KRISTENSEN M, Korsgaard U, Timm S, Hansen TF, et al The prognostic value of tumor budding in a thoroughly characterized stage II
colon cancer population in the context of a national screening program.
Hum Pathol. 2024 Feb 28:S0046-8177(24)00033. PubMedAbstract available
OZEKI H, Shimada Y, Nakano M, Kondo S, et al Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal
cancer.
Hum Pathol. 2024 Feb 27:S0046-8177(24)00032. PubMedAbstract available